Stockreport

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 [Financial Post (Toronto, Ontario, Canada)]

Adagene Inc. - ADS, each representing 1.25 ordinary shares  (ADAG) 
PDF transforming the discovery and development of novel antibody-based therapies, today announced its participation in the Leerink Partners Global Biopharma Conference 2024, [Read more]